Treatment of Gastric Cancer With Peritoneal Carcinomatosis by Cytoreductive Surgery and HIPEC: A Systematic Review of Survival, Mortality, and Morbidity

被引：199

作者：

Gill, Richdeep S. ^{[1
]}

Al-Adra, David P. ^{[1
]}

Nagendran, Jeevan ^{[1
]}

Campbell, Sandy ^{[2
]}

Shi, Xinzhe ^{[3
]}

Haase, Erika ^{[1
]}

Schiller, Daniel ^{[1
]}

机构：

[1] Univ Alberta, Dept Surg, Edmonton, AB, Canada

[2] Univ Alberta, Lib Serv, Edmonton, AB, Canada

[3] Royal Alexandra Hosp, Ctr Adv Minimally Invas Surg CAMIS, Edmonton, AB, Canada

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2011年 / 104卷 / 06期

关键词：

peritoneal carcinomatosis; gastric cancer; HIPEC; cytoreductive surgery; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; COLORECTAL-CANCER; RANDOMIZED-TRIAL; LEARNING-CURVE; DOXORUBICIN; MALIGNANCY; CISPLATIN; THERAPY; CHEMOHYPERTHERMIA; PHARMACOKINETICS;

D O I：

10.1002/jso.22017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Gastric cancer with peritoneal carcinomatosis has an extremely poor prognosis, which may be improved with cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC). We systematically reviewed the literature regarding the efficacy of CRS + HIPEC in these patients. Electronic databases were searched from 2000 to 2010. Following CRS + HIPEC, overall median survival was 7.9 months and improved to 15 months for patients with completeness of cytoreduction scores of 0/1, however with a 30-day mortality rate of 4.8%. J. Surg. Oncol. 2011;104:692-698. (C) 2011 Wiley Periodicals, Inc.

引用

页码：692 / 698

页数：7

共 55 条

[1]

Beaujard AC, 2000, CANCER-AM CANCER SOC, V88, P2512, DOI 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO

[2]

2-J

[3]

Recent patterns in gastric cancer: A global overview [J].